Acidic montmorillonite calcium hydroxide pharmaceutical composition, and preparation, product and application

Provided is an acidic montmorillonite calcium hydroxide sustained release compound medicine, the compound medicine consisting of the two active ingredients acidic montmorillonite and calcium hydroxide, and being sustainedly released by acidic montmorillonite adsorbing the calcium hydroxide in water, the formulation being 100 parts of acidic montmorillonite compounding with 20-95 parts of calcium hydroxide and 0.1-1 parts of fatty acid. With the sustained release and compounding with the acidic montmorillonite, the calcium hydroxide removes toxicity and controls side effects. The sustained-release compound medicine mainly acts on a local part, increasing the drug component content locally, thus improving performance. The sustained-release compound medicine is prepared into an enteric capsule having good antipyretic effect, anti-inflammatory effect, digestion and absorption promoting effect, anti-alcoholic and anti-drunkenness effect, and antihypertensive and anti-constipation effect. The sustained-release compound medicine can also be prepared into a spray and cataplasm having good functions of stopping bleeding, healing wounds and treating scalds.